Guido Sauter

108.3k total citations · 5 hit papers
600 papers, 35.0k citations indexed

About

Guido Sauter is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guido Sauter has authored 600 papers receiving a total of 35.0k indexed citations (citations by other indexed papers that have themselves been cited), including 267 papers in Molecular Biology, 240 papers in Oncology and 219 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guido Sauter's work include Prostate Cancer Treatment and Research (120 papers), HER2/EGFR in Cancer Research (80 papers) and Cancer Genomics and Diagnostics (74 papers). Guido Sauter is often cited by papers focused on Prostate Cancer Treatment and Research (120 papers), HER2/EGFR in Cancer Research (80 papers) and Cancer Genomics and Diagnostics (74 papers). Guido Sauter collaborates with scholars based in Germany, Switzerland and United States. Guido Sauter's co-authors include Michael J. Mihatsch, Ronald Simon, Lukas Bubendorf, Juha Kononen, Holger Moch, Peter Schraml, J. Torhorst, Martina Mirlacher, Olli Kallioniemi and Thomas C. Gasser and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Guido Sauter

587 papers receiving 34.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1998 3.2k citations J. Torhorst, Michael J. Mihatsch et al. profile →
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer

1997 1.4k citations Guido Sauter et al. profile →
Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients

2000 1.4k citations Guido Sauter, Holger Moch et al. profile →
Frequent EpCam protein expression in human carcinomas

2004 671 citations Alessandro Lugli, Guido Sauter et al. profile →
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

2003 502 citations Guido Sauter et al. PubMed profile →

Peers

Guido Sauter

ONCOL

PRM

SURGE

Holger Moch Switzerland

Ming‐Sound Tsao Canada

Robert B. Jenkins United States

Maria J. Merino United States

Ignacio I. Wistuba United States

José Baselga United States

Elizabeth A. Eisenhauer Canada

David L. Rimm United States

Masaki Mori Japan

Jeffrey S. Ross United States

Holger Moch Switzerland

Guido Sauter

18.3k ×1.0

11.4k ×0.8

ONCOL

14.7k ×1.5

PRM

9.7k ×1.2

6.3k ×1.2

SURGE

Citations per year, relative to Guido Sauter Guido Sauter (= 1×) peers Holger Moch

Countries citing papers authored by Guido Sauter

Since Specialization

Citations

This map shows the geographic impact of Guido Sauter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Sauter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Sauter more than expected).

Fields of papers citing papers by Guido Sauter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Sauter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Sauter. The network helps show where Guido Sauter may publish in the future.

Co-authorship network of co-authors of Guido Sauter

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Sauter. A scholar is included among the top collaborators of Guido Sauter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Sauter. Guido Sauter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grupp, Katharina, Martina Kluth, Claudia Hube‐Magg, et al.. (2024). CD10 Expression Correlates with Earlier Tumour Stages and Left-Sided Tumour Location in Colorectal Cancer but Has No Prognostic Impact in a European Cohort. Cancers. 16(8). 1473–1473. 1 indexed citations

Viehweger, Florian, Franziska Büscheck, Till S. Clauditz, et al.. (2024). Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors. Biomedicines. 12(5). 957–957. 3 indexed citations

Loga, Katharina von, Andrew Woolston, Marco Punta, et al.. (2020). Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer. Nature Communications. 11(1). 139–139. 43 indexed citations

Münscher, Adrian, Amit Gulati, Guido Sauter, et al.. (2018). Survivin expression in head and neck squamous cell carcinomas is frequent and correlates with clinical parameters and treatment outcomes. Clinical Oral Investigations. 23(1). 361–367. 12 indexed citations

Thewes, Verena, Ronald Simon, Magdalena Schlotter, et al.. (2015). Reprogramming of the ERRα and ERα Target Gene Landscape Triggers Tamoxifen Resistance in Breast Cancer. Cancer Research. 75(4). 720–731. 35 indexed citations

Burdelski, Christoph, Claudia Hube‐Magg, Martina Kluth, et al.. (2015). Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer. Clinical Cancer Research. 21(15). 3471–3479. 39 indexed citations

Lange, Tobias, Daniel Wicklein, Florian Gebauer, et al.. (2014). Aberrant Presentation of HPA-Reactive Carbohydrates Implies Selectin-Independent Metastasis Formation in Human Prostate Cancer. Clinical Cancer Research. 20(7). 1791–1802. 24 indexed citations

Stumm, Laura, Lia Burkhardt, Stefan Steurer, et al.. (2013). Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers. Journal of Clinical Pathology. 66(7). 563–568. 21 indexed citations

Burkhardt, Lia, Antje Krohn, Sawinee Masser, et al.. (2013). CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer. Cancer Research. 73(9). 2795–2805. 130 indexed citations

10.

Duhamel, Stéphanie, Josée Hébert, Louis Gaboury, et al.. (2012). Sef Downregulation by Ras Causes MEK1/2 to Become Aberrantly Nuclear Localized Leading to Polyploidy and Neoplastic Transformation. Cancer Research. 72(3). 626–635. 39 indexed citations

11.

Hudlebusch, Heidi Rye, Julie Skotte, Eric Santoni‐Rugiu, et al.. (2011). MMSET Is Highly Expressed and Associated with Aggressiveness in Neuroblastoma. Cancer Research. 71(12). 4226–4235. 50 indexed citations

12.

Hudlebusch, Heidi Rye, Eric Santoni‐Rugiu, Ronald Simon, et al.. (2011). The Histone Methyltransferase and Putative Oncoprotein MMSET Is Overexpressed in a Large Variety of Human Tumors. Clinical Cancer Research. 17(9). 2919–2933. 111 indexed citations

13.

Johnsen, Steven A., Cenap Güngör, Sabine Riethdorf, et al.. (2008). Regulation of Estrogen-Dependent Transcription by the LIM Cofactors CLIM and RLIM in Breast Cancer. Cancer Research. 69(1). 128–136. 52 indexed citations

14.

Olejniczak, Edward T., Charles Van Sant, Mark G. Anderson, et al.. (2007). Integrative Genomic Analysis of Small-Cell Lung Carcinoma Reveals Correlates of Sensitivity to Bcl-2 Antagonists and Uncovers Novel Chromosomal Gains. Molecular Cancer Research. 5(4). 331–339. 53 indexed citations

15.

Tornillo, Luigi, Alessandro Lugli, Inti Zlobec, et al.. (2007). Prognostic Value of Cell Cycle and Apoptosis Regulatory Proteins in Mismatch Repair–Proficient Colorectal Cancer. American Journal of Clinical Pathology. 127(1). 114–123. 23 indexed citations

16.

Aaboe, Mads, Karin Birkenkamp‐Demtröder, Carsten Wiuf, et al.. (2006). SOX4 Expression in Bladder Carcinoma: Clinical Aspects and In vitro Functional Characterization. Cancer Research. 66(7). 3434–3442. 137 indexed citations

17.

Tornillo, Luigi, Alessandro Lugli, Inti Zlobec, et al.. (2006). Prognostic Value of Cell Cycle and Apoptosis Regulatory Proteins in Mismatch Repair-Proficient Colorectal Cancer: A Tissue Microarray-Based Approach. American Journal of Clinical Pathology. 127(1). 114–123. 2 indexed citations

18.

Dahl, Edgar, Jürgen Veeck, Hong‐Mei An, et al.. (2005). [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer].. PubMed. 89. 169–77. 7 indexed citations

19.

Gasser, Thomas, et al.. (2000). Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma. Cancer. 89(3). 604–614. 373 indexed citations

20.

Sauter, Guido, Holger Moch, David A. Moore, et al.. (1993). Heterogeneity of erbB-2 gene amplification in bladder cancer.. PubMed. 53(10 Suppl). 2199–203. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact